A detailed history of Deka Bank Deutsche Girozentrale transactions in Merus N.V. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 56,000 shares of MRUS stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,000
Previous 56,000 -0.0%
Holding current value
$2.78 Million
Previous $3.33 Million 19.33%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$20.06 - $28.66 $621,860 - $888,460
31,000 Added 124.0%
56,000 $1.55 Million
Q3 2022

Nov 02, 2022

BUY
$18.64 - $28.93 $383,984 - $595,958
20,600 Added 468.18%
25,000 $487,000
Q1 2022

Apr 28, 2022

BUY
$23.58 - $30.91 $9,432 - $12,364
400 Added 10.0%
4,400 $117,000
Q4 2021

Feb 02, 2022

BUY
$20.0 - $32.29 $80,000 - $129,160
4,000 New
4,000 $127,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.